AAA DNA

Membership

Your membership dues help to strengthen our commitment to you, our alumni. The Alumni Society subsidizes an annual two-day scientific symposium at MSK, provide receptions at ASCO, and other regional meetings.

Join Today
Alumni Banner

Events

Each year, we host several social and educational opportunities designed to reconnect, engage and network with alumni.

Visit our Events page for details of upcoming events and meetings.

Visit the Events Calendar
On Cancer - Surgeons

About Us

The Memorial Hospital Alumni Society is a community unlike any other. Members range widely in age, live and work in different areas of the world, and represent the full spectrum of oncology specialties.

Learn More
Surgeons

Donations

The Memorial Hospital Alumni Society is a community unlike any other. Members range widely in age, live and work in different areas of the world, and represent the full spectrum of oncology specialties. Show your support by making a tax-deductible donation today.

Donate

About Us

The Memorial Hospital Alumni Society shares Memorial Sloan Kettering Cancer Center's commitment to the control and cure of cancer. To support this mission, the Alumni Society offers this Web site which features quick, searchable access to the entire alumni database.

By allowing members to contribute content, send e-mail, and register for events, the Alumni Society Web site will also serve to strengthen the community and social networking opportunities for Memorial-trained doctors.

Learn more about the Alumni Society
About Us

Photos From Past Events

To view photos from Memorial Hospital Alumni Society activities, first click on the album then click on any thumbnail photo to view the full-size photo. 

View the photos
Photos From Past Events

Featured Videos

View videos from our latest events, as well as speaking engagements from your fellow alumni. 

See all featured videos
Yelena Y. Janjigian, MD

In the News

msk_onconotes_may2019

OncoNotes - May 2019

Less Is Better: Promising Results for Reduced-Dose Radiation Therapy in High-Risk Pediatric Neuroblastoma

Reducing the radiation therapy dose currently used to treat high-risk neuroblastoma in children is possible, according to the promising results from our recent prospective trial, meaning reduced toxicities for many of these young patients.

Our study, published in the International Journal of Radiation Oncology, provides the first evidence that a dose reduction of three gray (Gy) — from 21 Gy to 18 Gy — can prevent local failure in pediatric neuroblastoma.

Read more

MSK OncoNotes - May 2019
MSK_ONCONOTES-Jan09

Sentinel Lymph Node Algorithm Noninferior to Full Pelvic Lymphadenectomy in Advanced Endometrial Cancer

Oncologic outcomes are similar with the use of a sentinel lymph node (SLN) algorithm compared to performing a full pelvic and paraaortic lymph node dissection (LND) in node-negative patients with deeply invasive endometroid endometrial carcinoma (EEC), according to our recent research, the first to compare these two assessment methods in this patient population.

Read more here

OncoNotes - January 2019
MSK_On_Cancer

Analyzing Spinal Fluid Could Guide Brain Tumor Diagnosis and Treatment

Studying mutational changes that occur in brain tumors has been difficult. A new approach involves analyzing cancer DNA that the tumor sheds into the fluid surrounding the brain and spinal cord. This fluid can be collected in biopsies to help with diagnosis and choosing treatment.

Read more here

On Cancer: January 23, 2019
More news

Noteworthy News

Dear Alumni,

We invite you to use the form below to add "Noteworthy News" to the alumni news items for all alumni to review. Please note that your news will be reviewed for approval before posting.